ログイン

IMMUNOLOGY AND SEROLOGY

IMMUNOLOGY AND SEROLOGY
60問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Which cells are capable of further differentiation in tissues? a. Lymphocyte b. Monocytes c. Neutrophils d. Dendritic cells

    b. Monocytes

  • 2

    What is the most significant agent formed in the phagolysosome for the killing of microorganisms? a. Proteolytic enzymes b. Hydroxyl radicals c. Hydrogen peroxide d. Superoxide

    c. Hydrogen peroxide

  • 3

    Which cell is the most potent phagocytic cell in the tissue? a. Neutrophil b. Dendritic cell c. Eosinophil d. Basophil

    b. Dendritic cell

  • 4

    Which of the following is a primary lymphoid organ? a. Lymph node b. Spleen c. Thymus d. MALT

    c. Thymus

  • 5

    Which of the following is found on the T cell subset known as helpers? a. CD19 b. CD4 c. CD8 d. CD56

    b. CD4

  • 6

    HLA-A, HLA-B, HLA-C belong to which MHC class? a. Class I b. Class II c. Class III d. Class IV

    a. Class I

  • 7

    HLA-DR, HLA-DQ, HLA-DP belong to which MHC class? a. Class I b. Class II c. Class III d. Class IV

    b. Class II

  • 8

    . T lymphocyte are incapable of functioning as: a. Cytotoxic cells b. Helper cells c. Phagocytic cells d. Regulatory cells

    c. Phagocytic cells

  • 9

    Antigen receptors on T lymphocyte bind HLA class II molecules with the help of which accessory molecule? a. CD2 b. CD3 c. CD4 d. CD8

    c. CD4

  • 10

    From the following, identify a specific component of the adaptive immune system that is formed in response to antigenic stimulation: a. Lysozyme b. Complement c. Commensal organism d. Immunoglobulin or antibodies

    d. Immunoglobulin or antibodies

  • 11

    Which immunoglobulin appears first in the primary immune response? a. IgG b. IgM c. IgA d. IgE

    b. IgM

  • 12

    Not true about IgM a. Highest in anamnestic response b. Has five subunits c. Predominant in primary immune response d. Immediate response

    a. Highest in anamnestic response

  • 13

    The key structural difference that distinguishes immunoglobulin subclasses: a. Stereometry of the hypervariable region b. Number of domains c. Sequence of the constant regions d. Covalent linkage of the light chains

    c. Sequence of the constant regions

  • 14

    Which antibody best protects mucosal surfaces? a. IgA b. IgG

    a. IgA

  • 15

    The subclasses of IgG differ mainly in: a. The type of L chain b. The arrangement of disulfide bonds c. The ability to act as opsonin d. Molecular weight

    b. The arrangement of disulfide bonds

  • 16

    Immunoglobulin that is the most efficient at crossing the placenta: a. IgG b. IgA c. IgM d. IgD

    a. IgG

  • 17

    Antibody idiotype is dictated by the: a. Constant region of heavy chain b. Constant region of light chain c. Constant region of heavy and light chains d. Variable regions of heavy and light chains

    d. Variable regions of heavy and light chains

  • 18

    . Antibody allotype is dictated by the: a. Constant region of heavy chain b. Constant region of light chain c. Constant region of heavy and light chains d. Variable regions of heavy and light chains

    c. Constant region of heavy and light chains

  • 19

    Unique amino acid sequence that is common to all immunoglobulin molecules of a given class in a given species: a. Isotype b. Allotype c. Idiotype d. None of the above

    a. Isotype

  • 20

    All antigen-antibody binding are: a. Reversible b. Irreversible c. Reversible or irreversible d. None of the above

    a. Reversible

  • 21

    All of the following are immunologic functions of complement, except: a. Induction of an antiviral state b. Opsonization c. Chemotaxis d. Anaphylatoxin formation

    a. Induction of an antiviral state

  • 22

    After the attachment of organism into the phagocyte, the pseudopodia surrounds the pathogen, after which the pseudopodia fuse to completely enclose the pathogen, forming a structure known as? a. Lysosome b. Phagolysosome c. Phagosome d. None of the above

    c. Phagosome

  • 23

    Which of the following cytokine is also known as the T-cell growth factor? a. IFN-gamma b. IL-12 c. IL-2 d. IL-10

    c. IL-2

  • 24

    Which would be the best assay to measure a specific cytokine? a. Blast formation b. T-cell proliferation c. Measurement of leukocyte chemotaxis d. ELISA testing

    d. ELISA testing

  • 25

    The classical complement pathway is activated by: a. Most viruses b. Antigen-antibody complexes c. Fungal cell walls d. Mannose in bacterial cell walls

    b. Antigen-antibody complexes

  • 26

    Which would be most effective in measuring an individual complement component? a. CH50 assay b. Radial immunodiffusion c. AH50 assay d. Lytic assay with liposome

    b. Radial immunodiffusion

  • 27

    Which best characterizes the secondary response? a. Equal amounts of IgM and IgG are produced b. There is an increase in IgM only c. There is a large increase in IgG but not IgM d. The lag phase is the same as in the primary response.

    c. There is a large increase in IgG but not Ig

  • 28

    When soluble antigens diffuse in a gel that contains antibody, in which zone does OPTIMUM precipitation occur? a. Prozone b. Zone of equivalence c. Postzone d. Prezone

    b. Zone of equivalence

  • 29

    Which technique represents a single-diffusion reaction? a. Radial immunodiffusion b. Ouchterlony diffusion c. Immunoelectrophoresis d. immunofixation electrophoresis

    a. Radial immunodiffusion

  • 30

    How much diluent needs to be added to 0.2 mL of serum to make a 1:20 dilution? a. 19.8 mL b. 4.0 mL c. 3.8 mL d. 10.0 mL

    c. 3.8 mL

  • 31

    Testing ANA have been helpful in: a. SLE detection b. RA detection c. Leukemia detection d. Hemolytic anemia detection

    a. SLE detection

  • 32

    Which of the following would be considered an organ-specific autoimmune disease? a. SLE b. RA c. GPA d. Hashimoto’s thyroiditis

    d. Hashimoto’s thyroiditis

  • 33

    Which of the following would support a diagnosis of drug-induced lupus? a. Antihistone antibodies b. Antibodies to Smith antigen c. Presence of RF d. Antibodies to SS-A and SS-B antigens

    a. Antihistone antibodies

  • 34

    A peripheral pattern of staining of the nucleus on IIF is caused by which of the following antibodies? a. Anti-Sm antibody b. Anti-SSA/Ro antibody c. Centromere antibody d. Anti-dsDNA

    d. Anti-dsDNA

  • 35

    Anti-CCP (cyclic citrullinated proteins) is specifically associated with which autoimmune disease? a. RA b. MG c. Autoimmune hepatitis d. Goodpasture’s syndrome

    a. RA

  • 36

    Anti-glomerular basement antibody is most often associated with this condition: a. Goodpasture disease b. SLE c. Celiac disease d. Chronic active hepatitis

    a. Goodpasture disease

  • 37

    To determine if a patient is allergic to rye grass, the best to perform is the: a. Total IgE b. Skin prick test c. DAT d. Complement fixation

    b. Skin prick test

  • 38

    Suppose a 30-year-old man was found to be a suitable donor for a kidney transplant to his younger sister. This transplant would be an example of a (an): a. Autograft b. Allograft c. Isograft d. Xenograft

    b. Allograft

  • 39

    Which of the following is being described? *One of the several types of cell surface molecules that regulate the activity of NK lymphocytes *These alloreactive NK cells have been shown to mediate GRAFT-VERSUS-LEUKEMIA (GVL) reaction. a. KO b. MICA c. KIRs d. HLA

    c. KIRs

  • 40

    Tumor markers found in the circulation are most frequently measure by: a. Immunoassays b. TLC c. HPLC d. Colorimetry

    a. Immunoassays

  • 41

    What clinical manifestation would be seen in a patient with myeloperoxidase deficiency? a. Defective T-cell function b. Inability to produce IgG c. Defective NK function d. Defective neutrophil function

    d. Defective neutrophil function

  • 42

    What is the best specimen for detection of latent syphilis? a. Blood b. Serum c. CSF d. Bone marrow

    c. CSF

  • 43

    Which test is recommended for testing CSF for detection of neurosyphilis? a. RPR b. VDRL c. FTA-ABS d. Enzyme immunoassay

    b. VDRL

  • 44

    Which serum antibody response usually characterizes the primary (early) stage of syphilis? a. Antibodies against syphilis are undetectable b. Detected 1–3 weeks after appearance of the primary chancre c. Detected in 50% of cases before the primary chancre disappears d. Detected within 2 weeks after infection

    b. Detected 1–3 weeks after appearance of the primary chancre

  • 45

    Which CD4:CD8 ratio is most likely in a patient with acquired immunodeficiency syndrome (AIDS)? a. 2:1 b. 3:1 c. 2:3 d. 1:2

    d. 1:2

  • 46

    Which tests are considered screening tests for HIV? a. ELISA, 4th generation, and rapid antibody tests b. Immunofluorescence, Western blot, radioimmunoprecipitation assay c. Culture, antigen capture assay, DNA amplification d. Reverse transcriptase and messenger RNA (mRNA) assay

    a. ELISA, 4th generation, and rapid antibody tests

  • 47

    Which tests are considered confirmatory tests for HIV? a. ELISA and rapid antibody tests b. Western blot test, HIC-1,2 differentiation assays, and polymerase chain reaction c. Culture, antigen capture assay, polymerase chain reaction d. Reverse transcriptase and mRNA assay

    b. Western blot test, HIC-1,2 differentiation assays, and polymerase chain reaction

  • 48

    Which is most likely a positive Western blot result for infection with HIV? a. Band at p24 b. Band at gp60 c. Bands at p24 and p31 d. Bands at p24 and gp120

    d. Bands at p24 and gp120 To be considered positive b

  • 49

    Interpret the following results for HIV infection: ELISA POSITIVE Repeat ELISA NEGATIVE Western blot NO BANDS a. Positive for HIV b. Negative for HIV c. Indeterminate d. Further testing needed

    b. Negative for HIV

  • 50

    The method of choice for detecting VZV infection in immunocompromised hosts is: a. Serology to detect virus-specific IgM antibodies b. Serology to detect virus-specific IgG antibodies c. Viral culture d. Real-time PCR

    d. Real-time PCR

  • 51

    The serum of an individual who received all doses of the hepatitis B vaccine should contain: a. anti-HBs b. anti-HBe c. anti-HBc d. All of the above

    a. anti-HBs

  • 52

    An individual with hepatomegaly, jaundice, and elevated liver enzymes has the following laboratory results: IgM anti-HAV negative, HBsAg (positive), IgM anti-HBc (positive), and anti-HCV (negative). These findings support a diagnosis of: a. Hepatitis A b. Acute hepatitis B c. Chronic hepatitis B d. Hepatitis C

    b. Acute hepatitis B

  • 53

    Interpretation of Hepatitis B panel: HBsAg negative Anti-HBc positive Anti-HBs positive a. Acutely infected b. Immune because of natural infection c. Immune because of hepatitis B vaccination d. Might be susceptible to a false-positive anti-HBc Immune status Anti-HBs Anti-HB

    b. Immune because of natural infection

  • 54

    In the streptozyme test, the RBCs of what organism are coated with streptolysin, streptokinase, hyaluronidase, DNase, and NADase? a. Horse b. Human c. Sheep d. Rabbit

    c. Sheep

  • 55

    In the RPR procedure, place the card on the rotator and rotate the card for: a. 100 RPM, 8 minutes b. 200 RPM, 8 minutes c. 100 RPM, 4 minutes d. 200 RPM, 4 minutes

    a. 100 RPM, 8 minutes

  • 56

    Current recommendation include the combined detection of mannan and anti-mannan antibodies for the specific identification of? a. Aspergillus species b. Candida species c. Cryptococcus species d. None of the above

    b. Candida species

  • 57

    The detection of galactomannan in serum by EIA has increased the ability to diagnose invasive: a. Aspergillus species b. Candida species c. Cryptococcus species d. None of the above

    a. Aspergillus species

  • 58

    In congenital toxoplasmosis, which class of antibodies is the most sensitive in detecting infection? a. IgA b. IgG c. IgM d. IgE

    a. IgA

  • 59

    Most the pathology associated with parasitic infections results form which of the following? a. Symbiotic relationships with the host b. Elaborate parasitic life cycles c. Immune response to the offending organism d. Innate defense mechanisms of the host

    c. Immune response to the offending organism

  • 60

    The chronic nature of parasitic infections is due to the host’s: a. Inability to eliminate the infective agent b. Type I hypersensitivity response to the infection c. Ability to form granuloma around the parasite d. Tendency to form circulating immune complexes

    a. Inability to eliminate the infective agen

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Which cells are capable of further differentiation in tissues? a. Lymphocyte b. Monocytes c. Neutrophils d. Dendritic cells

    b. Monocytes

  • 2

    What is the most significant agent formed in the phagolysosome for the killing of microorganisms? a. Proteolytic enzymes b. Hydroxyl radicals c. Hydrogen peroxide d. Superoxide

    c. Hydrogen peroxide

  • 3

    Which cell is the most potent phagocytic cell in the tissue? a. Neutrophil b. Dendritic cell c. Eosinophil d. Basophil

    b. Dendritic cell

  • 4

    Which of the following is a primary lymphoid organ? a. Lymph node b. Spleen c. Thymus d. MALT

    c. Thymus

  • 5

    Which of the following is found on the T cell subset known as helpers? a. CD19 b. CD4 c. CD8 d. CD56

    b. CD4

  • 6

    HLA-A, HLA-B, HLA-C belong to which MHC class? a. Class I b. Class II c. Class III d. Class IV

    a. Class I

  • 7

    HLA-DR, HLA-DQ, HLA-DP belong to which MHC class? a. Class I b. Class II c. Class III d. Class IV

    b. Class II

  • 8

    . T lymphocyte are incapable of functioning as: a. Cytotoxic cells b. Helper cells c. Phagocytic cells d. Regulatory cells

    c. Phagocytic cells

  • 9

    Antigen receptors on T lymphocyte bind HLA class II molecules with the help of which accessory molecule? a. CD2 b. CD3 c. CD4 d. CD8

    c. CD4

  • 10

    From the following, identify a specific component of the adaptive immune system that is formed in response to antigenic stimulation: a. Lysozyme b. Complement c. Commensal organism d. Immunoglobulin or antibodies

    d. Immunoglobulin or antibodies

  • 11

    Which immunoglobulin appears first in the primary immune response? a. IgG b. IgM c. IgA d. IgE

    b. IgM

  • 12

    Not true about IgM a. Highest in anamnestic response b. Has five subunits c. Predominant in primary immune response d. Immediate response

    a. Highest in anamnestic response

  • 13

    The key structural difference that distinguishes immunoglobulin subclasses: a. Stereometry of the hypervariable region b. Number of domains c. Sequence of the constant regions d. Covalent linkage of the light chains

    c. Sequence of the constant regions

  • 14

    Which antibody best protects mucosal surfaces? a. IgA b. IgG

    a. IgA

  • 15

    The subclasses of IgG differ mainly in: a. The type of L chain b. The arrangement of disulfide bonds c. The ability to act as opsonin d. Molecular weight

    b. The arrangement of disulfide bonds

  • 16

    Immunoglobulin that is the most efficient at crossing the placenta: a. IgG b. IgA c. IgM d. IgD

    a. IgG

  • 17

    Antibody idiotype is dictated by the: a. Constant region of heavy chain b. Constant region of light chain c. Constant region of heavy and light chains d. Variable regions of heavy and light chains

    d. Variable regions of heavy and light chains

  • 18

    . Antibody allotype is dictated by the: a. Constant region of heavy chain b. Constant region of light chain c. Constant region of heavy and light chains d. Variable regions of heavy and light chains

    c. Constant region of heavy and light chains

  • 19

    Unique amino acid sequence that is common to all immunoglobulin molecules of a given class in a given species: a. Isotype b. Allotype c. Idiotype d. None of the above

    a. Isotype

  • 20

    All antigen-antibody binding are: a. Reversible b. Irreversible c. Reversible or irreversible d. None of the above

    a. Reversible

  • 21

    All of the following are immunologic functions of complement, except: a. Induction of an antiviral state b. Opsonization c. Chemotaxis d. Anaphylatoxin formation

    a. Induction of an antiviral state

  • 22

    After the attachment of organism into the phagocyte, the pseudopodia surrounds the pathogen, after which the pseudopodia fuse to completely enclose the pathogen, forming a structure known as? a. Lysosome b. Phagolysosome c. Phagosome d. None of the above

    c. Phagosome

  • 23

    Which of the following cytokine is also known as the T-cell growth factor? a. IFN-gamma b. IL-12 c. IL-2 d. IL-10

    c. IL-2

  • 24

    Which would be the best assay to measure a specific cytokine? a. Blast formation b. T-cell proliferation c. Measurement of leukocyte chemotaxis d. ELISA testing

    d. ELISA testing

  • 25

    The classical complement pathway is activated by: a. Most viruses b. Antigen-antibody complexes c. Fungal cell walls d. Mannose in bacterial cell walls

    b. Antigen-antibody complexes

  • 26

    Which would be most effective in measuring an individual complement component? a. CH50 assay b. Radial immunodiffusion c. AH50 assay d. Lytic assay with liposome

    b. Radial immunodiffusion

  • 27

    Which best characterizes the secondary response? a. Equal amounts of IgM and IgG are produced b. There is an increase in IgM only c. There is a large increase in IgG but not IgM d. The lag phase is the same as in the primary response.

    c. There is a large increase in IgG but not Ig

  • 28

    When soluble antigens diffuse in a gel that contains antibody, in which zone does OPTIMUM precipitation occur? a. Prozone b. Zone of equivalence c. Postzone d. Prezone

    b. Zone of equivalence

  • 29

    Which technique represents a single-diffusion reaction? a. Radial immunodiffusion b. Ouchterlony diffusion c. Immunoelectrophoresis d. immunofixation electrophoresis

    a. Radial immunodiffusion

  • 30

    How much diluent needs to be added to 0.2 mL of serum to make a 1:20 dilution? a. 19.8 mL b. 4.0 mL c. 3.8 mL d. 10.0 mL

    c. 3.8 mL

  • 31

    Testing ANA have been helpful in: a. SLE detection b. RA detection c. Leukemia detection d. Hemolytic anemia detection

    a. SLE detection

  • 32

    Which of the following would be considered an organ-specific autoimmune disease? a. SLE b. RA c. GPA d. Hashimoto’s thyroiditis

    d. Hashimoto’s thyroiditis

  • 33

    Which of the following would support a diagnosis of drug-induced lupus? a. Antihistone antibodies b. Antibodies to Smith antigen c. Presence of RF d. Antibodies to SS-A and SS-B antigens

    a. Antihistone antibodies

  • 34

    A peripheral pattern of staining of the nucleus on IIF is caused by which of the following antibodies? a. Anti-Sm antibody b. Anti-SSA/Ro antibody c. Centromere antibody d. Anti-dsDNA

    d. Anti-dsDNA

  • 35

    Anti-CCP (cyclic citrullinated proteins) is specifically associated with which autoimmune disease? a. RA b. MG c. Autoimmune hepatitis d. Goodpasture’s syndrome

    a. RA

  • 36

    Anti-glomerular basement antibody is most often associated with this condition: a. Goodpasture disease b. SLE c. Celiac disease d. Chronic active hepatitis

    a. Goodpasture disease

  • 37

    To determine if a patient is allergic to rye grass, the best to perform is the: a. Total IgE b. Skin prick test c. DAT d. Complement fixation

    b. Skin prick test

  • 38

    Suppose a 30-year-old man was found to be a suitable donor for a kidney transplant to his younger sister. This transplant would be an example of a (an): a. Autograft b. Allograft c. Isograft d. Xenograft

    b. Allograft

  • 39

    Which of the following is being described? *One of the several types of cell surface molecules that regulate the activity of NK lymphocytes *These alloreactive NK cells have been shown to mediate GRAFT-VERSUS-LEUKEMIA (GVL) reaction. a. KO b. MICA c. KIRs d. HLA

    c. KIRs

  • 40

    Tumor markers found in the circulation are most frequently measure by: a. Immunoassays b. TLC c. HPLC d. Colorimetry

    a. Immunoassays

  • 41

    What clinical manifestation would be seen in a patient with myeloperoxidase deficiency? a. Defective T-cell function b. Inability to produce IgG c. Defective NK function d. Defective neutrophil function

    d. Defective neutrophil function

  • 42

    What is the best specimen for detection of latent syphilis? a. Blood b. Serum c. CSF d. Bone marrow

    c. CSF

  • 43

    Which test is recommended for testing CSF for detection of neurosyphilis? a. RPR b. VDRL c. FTA-ABS d. Enzyme immunoassay

    b. VDRL

  • 44

    Which serum antibody response usually characterizes the primary (early) stage of syphilis? a. Antibodies against syphilis are undetectable b. Detected 1–3 weeks after appearance of the primary chancre c. Detected in 50% of cases before the primary chancre disappears d. Detected within 2 weeks after infection

    b. Detected 1–3 weeks after appearance of the primary chancre

  • 45

    Which CD4:CD8 ratio is most likely in a patient with acquired immunodeficiency syndrome (AIDS)? a. 2:1 b. 3:1 c. 2:3 d. 1:2

    d. 1:2

  • 46

    Which tests are considered screening tests for HIV? a. ELISA, 4th generation, and rapid antibody tests b. Immunofluorescence, Western blot, radioimmunoprecipitation assay c. Culture, antigen capture assay, DNA amplification d. Reverse transcriptase and messenger RNA (mRNA) assay

    a. ELISA, 4th generation, and rapid antibody tests

  • 47

    Which tests are considered confirmatory tests for HIV? a. ELISA and rapid antibody tests b. Western blot test, HIC-1,2 differentiation assays, and polymerase chain reaction c. Culture, antigen capture assay, polymerase chain reaction d. Reverse transcriptase and mRNA assay

    b. Western blot test, HIC-1,2 differentiation assays, and polymerase chain reaction

  • 48

    Which is most likely a positive Western blot result for infection with HIV? a. Band at p24 b. Band at gp60 c. Bands at p24 and p31 d. Bands at p24 and gp120

    d. Bands at p24 and gp120 To be considered positive b

  • 49

    Interpret the following results for HIV infection: ELISA POSITIVE Repeat ELISA NEGATIVE Western blot NO BANDS a. Positive for HIV b. Negative for HIV c. Indeterminate d. Further testing needed

    b. Negative for HIV

  • 50

    The method of choice for detecting VZV infection in immunocompromised hosts is: a. Serology to detect virus-specific IgM antibodies b. Serology to detect virus-specific IgG antibodies c. Viral culture d. Real-time PCR

    d. Real-time PCR

  • 51

    The serum of an individual who received all doses of the hepatitis B vaccine should contain: a. anti-HBs b. anti-HBe c. anti-HBc d. All of the above

    a. anti-HBs

  • 52

    An individual with hepatomegaly, jaundice, and elevated liver enzymes has the following laboratory results: IgM anti-HAV negative, HBsAg (positive), IgM anti-HBc (positive), and anti-HCV (negative). These findings support a diagnosis of: a. Hepatitis A b. Acute hepatitis B c. Chronic hepatitis B d. Hepatitis C

    b. Acute hepatitis B

  • 53

    Interpretation of Hepatitis B panel: HBsAg negative Anti-HBc positive Anti-HBs positive a. Acutely infected b. Immune because of natural infection c. Immune because of hepatitis B vaccination d. Might be susceptible to a false-positive anti-HBc Immune status Anti-HBs Anti-HB

    b. Immune because of natural infection

  • 54

    In the streptozyme test, the RBCs of what organism are coated with streptolysin, streptokinase, hyaluronidase, DNase, and NADase? a. Horse b. Human c. Sheep d. Rabbit

    c. Sheep

  • 55

    In the RPR procedure, place the card on the rotator and rotate the card for: a. 100 RPM, 8 minutes b. 200 RPM, 8 minutes c. 100 RPM, 4 minutes d. 200 RPM, 4 minutes

    a. 100 RPM, 8 minutes

  • 56

    Current recommendation include the combined detection of mannan and anti-mannan antibodies for the specific identification of? a. Aspergillus species b. Candida species c. Cryptococcus species d. None of the above

    b. Candida species

  • 57

    The detection of galactomannan in serum by EIA has increased the ability to diagnose invasive: a. Aspergillus species b. Candida species c. Cryptococcus species d. None of the above

    a. Aspergillus species

  • 58

    In congenital toxoplasmosis, which class of antibodies is the most sensitive in detecting infection? a. IgA b. IgG c. IgM d. IgE

    a. IgA

  • 59

    Most the pathology associated with parasitic infections results form which of the following? a. Symbiotic relationships with the host b. Elaborate parasitic life cycles c. Immune response to the offending organism d. Innate defense mechanisms of the host

    c. Immune response to the offending organism

  • 60

    The chronic nature of parasitic infections is due to the host’s: a. Inability to eliminate the infective agent b. Type I hypersensitivity response to the infection c. Ability to form granuloma around the parasite d. Tendency to form circulating immune complexes

    a. Inability to eliminate the infective agen